Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy [Hematologic Malignancy]
Conclusion
Our study provides encouraging evidence for associations between loci at 5q23.2 and 6q21 with EFS and OS in patients with diffuse large B-cell lymphoma treated with immunochemotherapy, suggesting novel biology and the potential contribution of host genetics to the prognosis of this aggressive malignancy.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Ghesquieres, Slager, Jardin, Veron, Asmann, Maurer, Fest, Habermann, Bene, Novak, Mareschal, Haioun, Lamy, Ansell, Tilly, Witzig, Weiner, Feldman, Dogan, Cunningham, Olswold, Molina, Link, Milpied, Cox, Salles, Cerhan Tags: Epidemiology Hematologic Malignancy Source Type: research
More News: Biology | Cancer & Oncology | Clinical Trials | Epidemiology | Genetics | Hematology | Lymphoma | Molecular Biology | Study